Owner's Guides
Dental Practices for Sale: How to Sell a Dental Practice
Who is buying dental practices in the US right now, named DSOs and buyer types, the sale process and timeline, deal structures, and the mistakes that kill deals.
The consolidators are buying. On their terms or yours.
If you own a dental practice and you're starting to look at dental practices for sale as a comparison point, or thinking about selling a dental practice yourself, the first thing to understand is that the buyer market has split into two very different lanes. One is an individual dentist financing an asset purchase through a bank. The other is a dental support organization, or DSO, backed by private equity and buying transferable EBITDA. Both lanes are active. They price differently, structure differently, and ask for different things from you as the seller.
243 US dental transactions were publicly announced in 2024, up about 29% from 180 in 2023, making dental the most active physician-group subsector tracked by LevinPro. That count misses most of the doctor-to-doctor sales that never get announced. TUSK Practice Sales logged nearly 200 more transactions in the first half of 2026 alone. There is real buyer demand right now, at every size tier, and this page walks through who's buying, how the process runs, how deals get structured, and where sellers most often get hurt.
01
Who Is Buying Dental Practices Right Now
Roughly 16.1% of US dentists were DSO-affiliated in 2024, up from about 7.4% in 2015, and the share is much higher among younger dentists: about 27% of those fewer than 10 years out of school versus about 9% of those more than 25 years out. That's a structural shift in who ends up owning practices, not a fad.
Individual dentists and associates. Still the core buyer for a solo, owner-operated practice, usually financed through an SBA or bank loan. This buyer personally replaces you clinically, pays close to full cash at closing, and wants a short transition.
Dentist partnership organizations. Groups like MB2 Dental, Guardian Dentistry Partners, and SGA Dental Partners buy practices, often above $1 million in revenue, and let the seller retain or roll equity while keeping clinical autonomy. MB2 was the single most active buyer tracked in 2024, with 50 transactions, and closed a $525 million Warburg Pincus investment in November 2024. SGA merged with Gen4 and Modis in June 2026, creating a combined platform of more than 250 sites and 500 dentists across 26 states.
Traditional and PE-backed DSOs. Heartland Dental (19 transactions in 2024, KKR-backed), Dental Care Alliance, Sage Dental, Parkview Dental Partners, Smile Brands, and InterDent buy for cash plus employment, centralize back-office functions, and typically ask for 2 to 5 years of continued clinical work.
Specialty consolidators. Specialized Dental Partners (16 transactions in 2024) and specialty-focused arms of larger platforms target endodontic, oral surgery, periodontal, orthodontic, and pediatric practices, where referral relationships carry real value.
PE sponsors and platform buyers. Warburg Pincus-backed MB2 and KKR-backed Heartland represent the top of the market: multi-site platforms with $1 million or more in EBITDA, rollover equity, and management retention built into the deal.
No named DSO publishes a standard multiple, and offer structure varies enough between these categories that "who's the buyer" changes the shape of the deal more than any other single variable.
02
The Sale Process and a Realistic Timeline
A financeable, single-site practice typically takes 4 to 7 months from the start of preparation to closing. BizBuySell's current national dental median is 215 days on market, though that figure covers marketed listings and doesn't count the preparation work that happens before a practice ever goes to buyers.
| Stage | Typical duration | What you're doing |
|---|---|---|
| Exit and tax planning | 2 to 6 weeks | Decide entity structure, real estate treatment, personal goals, target buyer type |
| Financial normalization | 2 to 4 weeks | Pull 3 to 5 years of returns and P&Ls, trailing-12-month data, provider and hygiene reports |
| Legal and operational readiness | 2 to 6 weeks, overlapping | Lease review, licenses and permits, payer contracts, employee agreements, HIPAA posture |
| Confidential marketing and screening | 4 to 10 weeks | Teaser and CIM out under NDA, buyer proof of funds and licensure checked |
| Indications, meetings, LOI | 2 to 4 weeks | Compare enterprise value, cash at close, rollover, holdback, and required stay |
| Confirmatory diligence | 4 to 8 weeks | Chart sampling, payer mix, AR aging, equipment, compliance, board and claims history |
| Financing, credentialing, and documents | 6 to 12 weeks, overlapping | Bank appraisal, landlord consent or new lease, purchase agreement, payer and Medicaid filings |
| Closing and transition | 1 to 2 weeks to close, 30 to 90 days operational | Staff offers, patient notice, vendor and EFT cutover, funds flow |
If you're going the DSO route, add a workback period, commonly 2 to 5 years, tied to employment targets and earnout measurement. If your practice sits in California and the deal crosses the state's material-transaction thresholds, budget a minimum 90-day notice window before closing. Florida Medicaid practices need a 60-day change-of-ownership notice filed with the state before closing.
03
Valuation Summary: What Buyers Will Actually Pay
Valuation deserves its own deep treatment, so this section covers the summary you need to negotiate, not the full method. See our dental practice valuation page for the complete breakdown of collections, SDE, and adjusted EBITDA methods with a worked example.
The short version: individual and associate buyers price off collections and SDE, typically 0.55x to 0.90x collections or 1.6x to 3.5x SDE for the solo and small-group range. DSO buyers price off adjusted EBITDA after normalizing for market-rate clinician pay, and that range runs from roughly 4x to 6x for a straightforward add-on up to 9x to 11x for a platform-grade multi-location group with real management and systems in place. BizBuySell's 2025 reported sample put the median closed dental sale at $500,000, with an average of 0.87x revenue and 3.28x SDE, though that sample skews toward smaller owner-operated practices, not institutional deals.
A DSO's higher headline multiple often isn't higher cash. Compare the actual cash at close, not the number on the term sheet.
04
Deal Structures: Cash, Rollover, and Earnouts
How the price gets paid matters as much as the price itself.
| Buyer type | Cash at close | What's deferred or retained | Typical seller commitment |
|---|---|---|---|
| Individual dentist, bank-financed | Usually 90% to 100% | 0% to 10% seller note, sometimes more in a weaker deal | 2 to 12 weeks transition, occasionally part-time for 3 to 12 months |
| Associate or partner buyout | Often 70% to 100% | Seller note or staged buy-in, 10% to 30% | 1 to 3 years if staged |
| Traditional DSO acquisition | Often 70% to 90% | 10% to 30% as holdback, earnout, or rollover equity | Usually 2 to 5 years of clinical work |
| Joint-venture or partnership model | Often 60% to 85% | 15% to 40% retained equity in the practice or parent | Long-term leadership and clinical role |
| Platform sale or recapitalization | Negotiated majority cash | Meaningful rollover typically required | Management retention, 2 to 5 years |
Rollover equity and earnouts are not the same as cash. An earnout tied to production you no longer control, or equity in a platform you can't easily sell, carries real risk that a straight asset-purchase multiple doesn't. Real estate is a separate transaction, valued on local property income and comparable sales, not multiplied by the practice's EBITDA. Accounts receivable is normally handled one of three ways: retained and collected by you, purchased at an aging-based discount, or collected by the buyer under a fee arrangement. Get the treatment of prepaid treatment, membership plans, and lab cases written into the agreement, not assumed.
On tax, a dental practice sale is normally structured as an asset sale, with the price allocated across asset classes under IRC Section 1060 and reported on Form 8594 by both sides. Equipment depreciation recapture and inventory generally produce ordinary income for you; qualifying goodwill held more than a year usually gets capital-gain treatment. The buyer typically amortizes acquired goodwill and other intangibles over 15 years under Section 197. A C corporation asset sale can trigger tax at both the corporate and shareholder level, so model the after-tax number for your specific entity before you sign a letter of intent, not after.
05
State-Level Notes: Florida, California, and Beyond
Dental practice sales are governed heavily at the state level, and Florida and California in particular have rules worth knowing before you start a process.
Florida. Fla. Stat. §466.0285 bars a non-dentist entity from employing dentists or hygienists, controlling equipment used in patient care, or interfering with clinical judgment, pricing, records, or hours, outside a dentist-owned professional entity. Violations are third-degree felonies. Patient records generally must be kept for 4 years from the last treatment date under Fla. Stat. §466.018. Florida Medicaid practices need to notify AHCA and submit buyer enrollment materials at least 60 days before closing. Sale-of-practice noncompetes of 3 years or less are presumed reasonable under Fla. Stat. §542.335. Active Florida buyers include Dental Care Alliance (about 400 affiliated practices, Sarasota-based), Sage Dental (Boca Raton), Parkview Dental Partners, and Guardian Dentistry Partners (Miami).
California. Dental corporation ownership is restricted to licensed dentists under Business and Professions Code §§1800-1808 and Corporations Code §13407, which is why the dentist-owned professional corporation plus MSO structure exists. SB 351, effective 2026, bars PE or hedge-fund investors from interfering with clinical judgment and specified operational decisions, and limits noncompete and nondisparagement terms in PE and MSO arrangements. AB 1415 expanded the state's material-transaction notice rules starting January 1, 2026, requiring at least 90 days' notice before closing on covered deals, generally those involving parties above $25 million in California revenue or assets. Most single-site sales fall below the threshold, but check it before assuming otherwise. Active California buyers include MB2 Dental, Smile Brands (Irvine), InterDent (El Segundo, covering Gentle Dental and related brands), and PDS Health (Irvine).
Other states. North Carolina, New Jersey, and Texas each have their own dental practice act, corporate-practice-of-dentistry restrictions, and records rules, and buyer density varies by metro within each. We're building dedicated pages for these markets; until then, treat every state's ownership and noncompete statute as a separate legal check, not an assumption carried over from Florida or California.
06
Common Mistakes That Slow Down or Kill a Sale
Comparing multiples without matching the basis. A 7x EBITDA DSO offer and a 3x SDE private offer aren't the same number scaled differently. Reconcile the earnings definition before you compare anything.
Leaving your own labor in the EBITDA. Adding back all of your compensation without deducting what a replacement dentist actually costs inflates the number and won't survive a buyer's quality-of-earnings review or a lender's underwriting.
Ignoring the lease until late in diligence. A short term, missing options, no landlord consent, or a personal guaranty mismatch can stall or kill financing after everything else is agreed.
Assuming billing continuity. A buyer usually needs its own EIN, NPI, payer credentialing, and EFT setup. Plans to keep billing under your tax ID after closing don't work and create compliance exposure for both sides.
Overstating the active patient count. A database of names isn't an active patient list. Stale charts, low hygiene participation, and declining new-patient flow show up fast in diligence and get priced out.
Sitting on compliance and clinical issues. Incomplete cases, unsupported coding, sedation or radiography permit gaps, board matters, or unresolved malpractice claims surface in diligence regardless of when you disclose them, and they're cheaper to fix before a buyer finds them.
Leaving tax allocation to the lawyers at the end. You want more allocated to goodwill, the buyer wants more allocated to equipment and a noncompete. Settle the allocation approach before price, not after.
07
Frequently Asked Questions
It depends on the buyer. Individual-buyer transitions can be a matter of weeks or months. DSOs commonly require 2 to 5 years of continued clinical work, especially if part of your consideration is an earnout or rollover equity tied to future performance. A practice already run mostly by associates can usually negotiate a shorter stay.
The DSO may be pricing in density, systems, and future platform value, but part of that higher number is often rollover equity, a holdback, or an earnout rather than cash, and it can come with 2 to 5 years of required work. Compare risk-adjusted proceeds, not the headline multiple.
Some attrition is normal in any transition. It's worse when the practice is inseparable from you personally, when the buyer changes fee schedules or payer participation, or when staff leave and communication is abrupt. A coordinated patient letter and a real introduction period reduce the risk but don't eliminate it.
An associate typically offers continuity and a shorter transition, usually with cleaner terms, but less capital and no competitive-auction premium. Get an independent valuation, separate counsel for both sides, and a real deadline so an internal negotiation doesn't quietly block outside offers.
No, but you still need a dental transaction attorney, a tax CPA, valuation support, and a way to run confidential buyer outreach and compare competing offers. Weigh any broker fee against the realistic increase in price and certainty of closing, not against a hope that it's automatic.
AR can stay with you, get purchased at a discount reflecting its age, or get collected by the buyer for a fee. Whichever way you go, the purchase agreement needs to explicitly cover patient credit balances, prepaid treatment, lab cases, membership plans, and remakes so nothing falls through the cracks at closing.